ArticleGlobal health research and policy2024

Uptake of biosimilars in China: a retrospective analysis of the case of trastuzumab from 2018 to 2023.

Qiyou Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.